News GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 19:35:01 06/03/2026 +03			5-day change	1st Jan Change
2,038.00 ^GBX	-1.83%		-7.41%	+11.70%

03-05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI
03-05	GSK outgoing CEO Emma Walmsley's 2025 total remuneration was 15.7 mln pounds vs 10.6 mln pounds in 2024 - annual report	RE

All News

03-05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI
03-05	GSK outgoing CEO Emma Walmsley's 2025 total remuneration was 15.7 mln pounds vs 10.6 mln pounds in 2024 - annual report	RE
03-05	GSK : Governance And Remuneration Report 2025	PU
03-05	GSK : Responsible Business Report 2025	PU
03-05	GSK : Cautionary statement 2025	PU
03-04	When Talk of Talks Moves Markets
03-04	Remember 2022
03-04	Rosebank fundraise; Surface Transforms loses GM deal	AN
03-04	Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute	RE
03-03	Fda approves first generic of Flovent HFA for treatment of asthma	RE
03-03	GSK plc completed the acquisition of 93.4% stake in RAPT Therapeutics, Inc. for $1.7 billion.	CI
03-03	GSK Completes Purchase of RAPT Therapeutics	MT
03-03	GSK Wraps Up $2.2 Billion Deal to Buy US-based Rapt Therapeutics	MT
03-03	GSK : completes acquisition of RAPT Therapeutics	PU
03-02	A Very Dangerous Gamble
03-02	GSK : Sell rating from JP Morgan	ZD
03-02	Price targets raised for BP and Shell	AN
03-02	A Leap into the Unknown
02-27	GSK plc - Linerixibat accepted for priority review in China for cholestatic pruritus in patients with primary biliary cholangitis	AQ
02-27	EU regulator backs approval for Moderna's combined COVID and flu vaccine	RE
02-26	European Stocks Mixed in Thursday Trading; Economic Expectations Lower in EU, Euro Area	MT
02-26	GSK : Jefferies reiterates its Buy rating	ZD
02-26	GSK enters agreement to acquire 35Pharma Inc.	AQ
02-26	GSK : Barclays reaffirms its Sell rating	ZD
02-26	The Bar Just Moved Higher